Transaction in Own Shares

Summary by AI BETAClose X

Worldwide Healthcare Trust PLC announced the purchase of 2,000,000 Ordinary shares of 2.5p each at a price of 328.34 pence per share. The purchase was made under the authority granted at the Annual General Meeting on July 9, 2025, which allowed for market purchases of up to 69,602,221 shares. Following the transaction, the company holds 192,527,231 Ordinary shares in treasury. The total number of Ordinary shares in issue is now 601,665,200, resulting in a total number of voting rights of 409,137,969. This figure may be used by shareholders to determine if they need to notify their interest in the company under FCA rules.

Disclaimer*

 

For immediate release

24 September 2025

 

WORLDWIDE HEALTHCARE TRUST PLC

(the "Company")

 

 

MARKET PURCHASE OF COMPANY'S OWN SHARES

 

 

 

This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 9 July 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 69,602,221.

 

The Company has purchased a market total of 2,000,000 Ordinary shares of 2.5p each in the capital of the Company today at a price of 328.34 pence per share. These shares will be held in treasury.

 

Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 192,527,231 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 409,137,969.

 

The figure of 409,137,969 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

For and on behalf of

Frostrow Capital LLP

Company Secretary

 

For further information, please contact:

 

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913

 




UK 100

Latest directors dealings